throbber
USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 1 of 56
`
`
`
`
`
`
`
` [PUBLISH]
`
`
`
`
`
`
`
`
`In the
`United States Court of Appeals
`For the Eleventh Circuit
`
`
`
`
`
`
`
`
`
`____________________
`
`Nos. 20-13091, 20-14377
`
`____________________
`
`
`UNITED STATES OF AMERICA,
`
`versus
`
`ELIZABETH PETERS YOUNG,
`
`
` Plaintiff-Appellee,
`
` Defendant- Appellant.
`
`
`____________________
`
`Appeals from the United States District Court
`for the Southern District of Florida
`D.C. Docket No. 0:19-cr-60157-RAR-1
`____________________
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 2 of 56
`
`2
`
`Opinion of the Court
`
`20-13091
`
`Before JORDAN, ROSENBAUM, Circuit Judges, and MANASCO,* Dis-
`trict Judge.
`
`ROSENBAUM, Circuit Judge:
`
`Under the federal Anti-Kickback statute, it’s illegal to make
`or accept payments for referring business that a federal program
`will reimburse. Among other functions, this law helps ensure that
`medicine-related decision-makers do not make decisions for finan-
`cial-enrichment reasons but rather for the patient’s benefit.
`
`Here, a jury convicted Defendant Elizabeth Peters Young of
`conspiring to pay and receive kickbacks from federal reimburse-
`ments for medical creams and lotions that the pharmacies she
`worked with dispensed. As part of Young’s sentence, the district
`court ordered Young to make restitution in the amount of $1.5 mil-
`lion to the federal government, based on the amount of kickbacks
`Young received. The court also entered a forfeiture judgment
`against Young in that same amount because it represented the
`gross proceeds Young controlled during the conspiracy.
`
`Young now challenges her conspiracy conviction, the resti-
`tution order, and the forfeiture judgment. She asserts that insuffi-
`cient evidence supported her conspiracy conviction, that the gov-
`ernment did not meet its burden to support the restitution amount,
`
`
`* Honorable Anna M. Manasco, United States District Judge for the Northern
`District of Alabama, sitting by designation.
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 3 of 56
`
`20-13091
`
`Opinion of the Court
`
`3
`
`and that the district court erred in calculating the forfeiture
`amount.
`
`After careful review of the record and with the benefit of
`oral argument, we affirm Young’s conspiracy conviction. We also
`affirm the district court’s forfeiture judgment as consistent with
`controlling precedent. But we agree with Young that the district
`court erred in crafting the restitution order. Because the govern-
`ment did not establish that the amount of loss it experienced as a
`result of Young’s conduct equaled the total amount of kickbacks
`Young possessed during the conspiracy, we vacate the restitution
`order and remand for further proceedings consistent with this opin-
`ion.
`
`I.
`
`A.
`
`BACKGROUND
`
`Factual Background
`
`Young had a career marketing medical products to sur-
`geons. She often spent time in the operating room during surgery
`in case her surgeon clients needed assistance with the products she
`sold them, and she developed relationships with her clients.
`
`Around 2012, Young started her own distributorship, Young
`Surgical, LLC. Young Surgical initially sold devices related to spi-
`nal surgeries, as that was Young’s area of expertise.
`
`But in early 2015, Young decided to start marketing over-
`the-counter pain-relieving patches and creams to doctors who
`treated workers’ compensation patients. The patches went by the
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 4 of 56
`
`4
`
`Opinion of the Court
`
`20-13091
`
`brand name Terocin, and the creams went by the brand name Li-
`doPro. Terocin and LidoPro were expensive. So only a few
`healthcare programs, including the Federal Employees’ Compen-
`sation Act (“FECA”) program, administered by the Department of
`Labor’s Office of Workers’ Compensation Programs, would pay
`for them. Those programs applied an extremely high rate in reim-
`bursing the pharmacies that provided Terocin and LidoPro. For
`instance, a program paid one providing pharmacy $802 for Tero-
`cin, even though the product cost the pharmacy only $200, plus $16
`in shipping.
`
`Young decided that she would try to sell the patches and
`creams to Dr. Plas James, one of Young Surgical’s clients who
`owned and operated a practice in Georgia. So she approached Dr.
`James’s medical assistant and office manager, Desiree de la Cruz.1
`Young and de la Cruz had been friends for more than fifteen years.
`Over the years, Young had helped de la Cruz by buying her food
`and, on one occasion, even giving her a car. In February 2015,
`Young asked de la Cruz to tell Dr. James about Young’s new ven-
`ture selling Terocin and LidoPro.
`
`After meeting with de la Cruz, Young looked for a pharmacy
`that could provide Terocin and LidoPro. A Google search led her
`to a pharmacy in Pompano Beach, Florida, called Drugs4Less.
`
`
`1 At some point during the events in this case, de la Cruz’s name changed to
`Desiree Mitchell. To avoid confusion with co-conspirator Tim Mitchell, we
`refer to her throughout this opinion as Desiree de la Cruz.
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 5 of 56
`
`20-13091
`
`Opinion of the Court
`
`5
`
`Drugs4Less had a surplus of Terocin and LidoPro and had experi-
`enced trouble offloading them because of their expense.
`
`Young contacted the owner of Drugs4Less, Dr. Amir Serri,
`and they entered into a contract under which Young would receive
`a kickback of 50% of the net profits from the prescriptions she was
`able to direct to Drugs4Less. Drugs4Less then sent a few samples
`of Terocin and LidoPro to Dr. James, who agreed to use the prod-
`ucts with his patients.
`
`Around the same time, Young hired Tim Mitchell as a sales
`representative for Young Surgical. Mitchell and de la Cruz were
`living together then and later married. Before Young hired him,
`Mitchell had been a cashier and had held some positions as a sales
`representative, including for Aflac. But he had never worked in the
`healthcare industry.
`
`Young was not concerned about Mitchell’s lack of experi-
`ence, though. She hired him because of his relationship with de la
`Cruz, whom Young described as a “unicorn.” A “unicorn,” for
`these purposes, is someone who “worked in an office that had ac-
`cess to the doctor [and] had the ability to give everybody that came
`through a prescription,” which was “very, very rare” and “unique.”
`Whether or not it’s true that de la Cruz had the ability to “give”
`every patient a prescription for Terocin and LidoPro, the evidence
`showed that de la Cruz participated in securing prescriptions for
`Dr. James’s patients. For example, Young said de la Cruz “wr[ote]”
`“script[s],” and Young sent an email saying, “With all of [de la
`Cruz’s] refills today, we’re at nine thousand for the day.”
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 6 of 56
`
`6
`
`Opinion of the Court
`
`20-13091
`
`With Mitchell onboard as her sales representative and de la
`Cruz involved in processing prescriptions for Dr. James, Young im-
`plemented her kickback scheme. It worked like this: Dr. James
`saw patients in Georgia who sought treatment for injuries. He of-
`ten prescribed pain patches and creams to his patients. And Young
`made it easy for him to prescribe Terocin and LidoPro, between de
`la Cruz’s presence in Dr. James’s office and Young’s provision of
`preprinted prescription pads with the drug names Terocin and Li-
`doPro in large print and the generic form of the drugs in small print
`underneath.2
`When Dr. James prescribed Terocin or LidoPro to patients
`who were eligible for federal workers’ compensation, de la Cruz
`sent those prescriptions to be filled at the Drugs4Less pharmacy,
`even though it was located in Florida. Drugs4Less then filled the
`prescriptions, shipped the patches and creams for free to the pa-
`tients, and sent a bill to the FECA program in the Office of Work-
`ers’ Compensation Programs. That office reimbursed Drugs4Less
`at the extremely high rates Terocin and LidoPro supported, and
`Drugs4Less in turn sent half its profits to Young. Young then sent
`20% of her revenue to Mitchell for de la Cruz’s services.
`
`The co-conspirators focused on Terocin and LidoPro be-
`cause of their high reimbursement rates. In an email to her
`Drugs4Less contact, Young even called “adding [L]ido[P]ro” her
`
`
`2 The government does not assert that Dr. James was involved in Young’s
`scheme.
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 7 of 56
`
`20-13091
`
`Opinion of the Court
`
`7
`
`“best idea EVER.” And in response to an email from Drugs4Less
`asking about refills on Terocin patches, de la Cruz responded, “Re-
`fills for everyone!!!!!!!” But if federal programs denied prescriptions
`for Terocin or LidoPro, Dr. James’s office would not prescribe an
`alternative treatment, further highlighting that the scheme relied
`on the high rates Terocin and LidoPro supported.
`
`The scheme was a huge financial success. Just a few months
`into the venture, Young and Drugs4Less enjoyed their first month
`with over $100,000 in profits. By the end of August 2015, Young’s
`monthly share of the profits reached $134,952. In total, in the
`roughly sixteen months between March 2015 and July 2016, Young
`received $1,228,404 from Drugs4Less based on reimbursements
`from workers’ compensation programs, the vast majority of which
`came from the FECA program.
`
`Of this, Young sent Mitchell $338,255 as purported compen-
`sation for his work as a sales representative. In reality, though, as
`we’ve noted, these payments were kickbacks to de la Cruz for send-
`ing the prescriptions to Drugs4Less. Indeed, Mitchell testified at
`trial that he did no work at all in his position as a sales representa-
`tive for Young Surgical. He merely waited for the checks to come
`in each month as compensation for de la Cruz’s work securing the
`prescriptions.
`
`The arrangement continued through the summer of 2016.
`Around that time, Young took a few steps to try to limit the legal
`exposure from her scheme. First, Young had Mitchell sign a decla-
`ration stating that he didn’t try to influence Dr. James and that Dr.
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 8 of 56
`
`8
`
`Opinion of the Court
`
`20-13091
`
`James made all the medical decisions. Second, she sent Mitchell
`emails purporting to seek assurances that de la Cruz was not in a
`position of authority to award the referral of business (even though
`that was the reason Young hired Mitchell). Third, she arranged a
`training opportunity for Mitchell so he would appear to be a bona
`fide sales representative. And fourth, she asked Dr. Serri to hire
`Mitchell and herself as employees of Drugs4Less, which she hoped
`would shield her from liability under the Anti-Kickback Statute.
`
`But Dr. Serri refused to hire Young and Mitchell. So Young
`terminated the relationship with Drugs4Less and found employ-
`ment for herself and Mitchell at another pharmacy. Apparently un-
`able to find a cooperating pharmacy in Georgia, where the patients
`were located, or Florida, where Drugs4Less was, Young completed
`the Eleventh Circuit trifecta and went with Gateway Pharmaceuti-
`cals, a pharmacy in Birmingham, Alabama.
`
`Still, Young continued the same arrangement she had with
`Mitchell and de la Cruz, with only two differences. First, de la Cruz
`routed the Terocin and LidoPro prescriptions to Gateway instead
`of Drugs4Less. And second, because Mitchell was an employee of
`Gateway, Gateway paid him directly, so Young did not have to pay
`Mitchell anymore. From September 2016 through December
`2018, Gateway paid $298,756 to Young and $209,572 to Mitchell.
`
`All told, during the scheme, the FECA program reimbursed
`$1,863,649 to Drugs4Less and $1,092,919 to Gateway for Terocin
`and LidoPro prescriptions. Young received $1,527,160.75 in total
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 9 of 56
`
`20-13091
`
`Opinion of the Court
`
`9
`
`between the two pharmacies, and she passed $338,255 of that to
`Mitchell.
`
`B.
`
`Procedural History
`
`A federal grand jury returned an indictment against Young
`for her role in the kickback scheme. The Indictment charged
`Young with one count of conspiracy to pay and receive healthcare
`kickbacks in connection with the FECA program, in violation of 18
`U.S.C. § 371, 42 U.S.C. §§ 1320a-7b(b)(1)(A), and 1320a-7b(b)(2)(A);
`six counts of receiving healthcare kickbacks in connection with the
`FECA program, in violation of 42 U.S.C. § 1320a-7b(b)(1)(A); and
`four counts of paying healthcare kickbacks in connection with the
`FECA program, in violation of 42 U.S.C. § 1320a-7b(b)(2)(A).
`
`Young moved to transfer venue to the Northern District of
`Georgia, or alternatively, to dismiss based on improper venue. Af-
`ter a hearing, the district court denied Young’s motion with respect
`to the conspiracy count, the payment counts, and three of the re-
`ceipt counts, and the court dismissed the three remaining receipt
`counts.
`
`The surviving counts proceeded to a jury trial. The govern-
`ment called six witnesses, including Mitchell, as part of its case-in-
`chief.3 Mitchell testified that Young and de la Cruz enjoyed a
`
`
`3 For their roles in the conspiracy, Mitchell and de la Cruz both pled guilty to
`one count of conspiracy to receive healthcare kickbacks. Mitchell was sen-
`tenced to 60 months’ probation, including 12 months’ home detention, and he
`
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 10 of 56
`
`10
`
`Opinion of the Court
`
`20-13091
`
`longstanding close friendship. In 2015, Mitchell recounted, de la
`Cruz told Mitchell that Young had offered them an opportunity to
`make some money. So Mitchell and de la Cruz met with Young at
`a Chick-Fil-A, where Young explained that she wanted Mitchell to
`“focus on selling” LidoPro and Terocin to Dr. James, de la Cruz’s
`longtime employer. Mitchell noted that de la Cruz had a “[v]ery
`close” relationship with Dr. James.
`
`According to Mitchell, he had no knowledge of healthcare
`products, and Young provided no training or instruction. Although
`Mitchell tried to sell LidoPro and Terocin to a couple other doc-
`tors, Mitchell said, Young discouraged him from spending his time
`that way. And as for Dr. James, Mitchell never “pitch[ed]” him,
`marketed to him, presented to him on Terocin and LidoPro, or
`even provided him with samples. Instead, Mitchell testified, Young
`relied on de la Cruz’s “great relationship” with Dr. James. Young
`told Mitchell that “[e]very patient that comes through [Dr. James’s
`office] will get our patches and cream” because of de la Cruz.
`
`As Mitchell recounted his position with Young, de la Cruz
`did “all the work and [Mitchell] . . . ma[de] extremely good
`money.” But Young told Mitchell “not to do anything” in exchange
`for the money.
`
`
`was ordered to forfeit his illicit gains in the amount of $457,586 and pay that
`same amount in restitution. De la Cruz was sentenced to 12 months and 1
`day of imprisonment, and she was held jointly and severally liable for Mitch-
`ell’s restitution obligations.
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 11 of 56
`
`20-13091
`
`Opinion of the Court
`
`11
`
`Mitchell explained that de la Cruz was Dr. James’s back of-
`fice manager, so she was able to ensure that all his patients were
`prescribed LidoPro. According to Mitchell, it was de la Cruz who
`obtained the prescriptions for Terocin and LidoPro from Dr.
`James, de la Cruz who sent those prescriptions to the pharmacy,
`and de la Cruz who handled patient issues. Mitchell noted that en-
`suring that no patients complained was important because Young
`told him that “[i]f complaints got back to Dr. . . . James, he would
`have immediately shut down our operation.” Although, by his
`own testimony, Mitchell did “nothing,” he was paid “[a]round 450-
`something thousand dollars.” Mitchell opined that he received
`payment instead of de la Cruz to avoid having de la Cruz’s involve-
`ment raise “a red flag that would draw attention.”
`Mitchell also said that Young directed him to take steps to
`make the arrangement seem legitimate. For instance, he men-
`tioned that Young instructed him to start his own company solely
`for the purpose of depositing Young’s payments because “it looked
`better in regards to depositing those kind[s] of checks into a busi-
`ness account [as] opposed to a personal account.” Similarly, Mitch-
`ell recounted that Young told him to remove de la Cruz’s name
`from certain bank accounts. And when it came to payment, Mitch-
`ell testified that on several occasions before he opened the bank
`account in the name of his own company, Young split Mitchell’s
`payment into two or more checks, so no check totaled $10,000 or
`more. But after he opened his company’s bank account, Young
`paid him with checks well over $10,000.
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 12 of 56
`
`12
`
`Opinion of the Court
`
`20-13091
`
`For her part, Young also engaged in acts to falsely make her
`arrangement with Mitchell seem legitimate, Mitchell said. For ex-
`ample, after Mitchell and de la Cruz returned from their honey-
`moon, Young sent Mitchell an email that said, “Now that you and
`[de la Cruz] are married, I must assume that there is the potential
`of co-mingling your personal funds.” Yet for more than a year be-
`fore their marriage, Mitchell testified, Young knew that Mitchell
`and de la Cruz lived together, had given checks to de la Cruz for
`Mitchell, and was aware that Mitchell and de la Cruz had already
`been “co-mingling funds.” Still, Young’s email continued, “I must,
`with a reasonable amount of certainty, be sure that [de la Cruz] is
`not in a position of any authority to award the referral of business,”
`and then quoted the federal anti-kickback statute.
`
` Then, when Young started using Gateway instead of
`Drugs4Less to provide the products, Mitchell testified, he moved
`right along with Young. According to Mitchell, “My wife. Every-
`thing. The whole organization. Everything[]” moved to Gateway.
`Young also sent Mitchell a contract with Gateway to sign. Under
`the contract, Mitchell agreed to work as a marketing representative
`of Gateway.
`
`But in actuality, Mitchell continued to do nothing. And
`Cruz continued to refer Dr. James’s patients—this time to Gate-
`way.
`
`Mitchell also testified that he had pled guilty to conspiring
`to violate the anti-kickback law because he “was guilty.” According
`to Mitchell, he conspired with de la Cruz, Young, Drugs4Less, and
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 13 of 56
`
`20-13091
`
`Opinion of the Court
`
`13
`
`Gateway. Mitchell explained that he was testifying against Young
`in the hope of receiving a reduced sentence.
`
`Besides Mitchell, the government called Vanessa Hernan-
`dez, a pharmacy technician at Drugs4Less. Hernandez testified
`that Dr. Serri sought a way to unload his inventory of Terocin and
`LidoPro, that de la Cruz was Hernandez’s point of contact at Dr.
`James’s office, and that Hernandez kept Young updated on prob-
`lems with prescriptions. Those issues included instances like when
`the Office of Workers’ Compensation declined to reimburse a par-
`ticular order.
`
`And when Hernandez found the prescribing physician’s sig-
`nature illegible, she called de la Cruz for verification. On occasion,
`Hernandez continued, de la Cruz also phoned in prescriptions and
`approved refills on behalf of Dr. James.
`
`On another note, Hernandez explained that sometimes, an
`insurer declined to pay for a particular prescription, but it was pos-
`sible to receive coverage for an equivalent prescription. When the
`insurer denied payment for LidoPro and Terocin, though, Hernan-
`dez said, typically, no one sought an equivalent substitute.
`
`Young testified in her own defense. She claimed that all the
`payments she received from the pharmacies were legitimate pay-
`ments for marketing and customer referrals. She also testified that
`all payments she made to Mitchell were for his legitimate work as
`a sales representative. Young also called several other witnesses to
`testify on her behalf, including former supervisors and colleagues
`who had worked with her.
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 14 of 56
`
`14
`
`Opinion of the Court
`
`20-13091
`
`After a ten-day trial, the jury convicted Young on the con-
`spiracy count and the four counts related to paying kickbacks. The
`jury acquitted Young on the three remaining counts related to re-
`ceiving kickbacks.
`
`Young moved to set aside the verdict or conduct a new trial.
`But the district court denied her motion. The court sentenced
`Young to 57 months’ imprisonment and three years of supervised
`release.
`
`In connection with Young’s sentencing, the government
`moved for a preliminary criminal forfeiture order under 18 U.S.C.
`§ 982(a)(7). Under that provision, a court can order healthcare de-
`fendants to forfeit property “that constitutes or is derived, directly
`or indirectly, from gross proceeds traceable to the commission of
`the offense.” 18 U.S.C. § 982(a)(7). The government sought forfei-
`ture in the amount of $1,527,160.75, which represented the total
`amount Young received in kickbacks in exchange for referrals of
`Terocin and LidoPro to Drugs4Less and Gateway.
`
`Young opposed the motion on several grounds, three of
`which she continues to press on appeal: (1) any money that she
`transferred to co-conspirators should be excluded from the forfei-
`ture total under the Supreme Court’s decision in Honeycutt v. United
`States, 581 U.S. 443 (2017); (2) any money derived from private in-
`surers should be excluded; and (3) the total amount is an excessive
`fine in violation of the Eighth Amendment.
`
`After a hearing, the district court accepted the government’s
`proposed forfeiture amount. It found Young liable for the gross
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 15 of 56
`
`20-13091
`
`Opinion of the Court
`
`15
`
`proceeds of the conspiracy under Honeycutt and ordered forfeiture
`of the total amount deposited into her account—$1,527,160.75—
`no matter whether those funds came from government funds or
`private insurers.
`
`The district court also conducted a separate restitution hear-
`ing. The government sought restitution in the amount of
`$1,527,160.75—the same as the forfeiture amount. Young chal-
`lenged that proposed amount. She asserted that the government
`did not prove that any of the reimbursements she received were
`fraudulent and warranted restitution.
`
`The district court concluded that the value of the kickbacks
`could serve as the starting point to determine restitution. It also
`found that the government had sufficiently shown that Young’s
`scheme involved fraud and that Young had not offered evidence to
`establish that the patches and creams she provided were medically
`necessary. So the district court ordered restitution for the full
`amount of the kickbacks, $1,527,160.75.
`
`Young timely appealed the initial judgment and prison sen-
`tence. She also appealed the amended judgment, which included
`the forfeiture and restitution penalties. We consolidated Young’s
`appeals.
`
`II.
`
`STANDARDS OF REVIEW
`
`We review de novo a defendant’s challenge to the suffi-
`ciency of the evidence underlying her conviction. United States v.
`Dixon, 901 F.3d 1322, 1335 (11th Cir. 2018). In so doing, we “view
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 16 of 56
`
`16
`
`Opinion of the Court
`
`20-13091
`
`the evidence in the light most favorable to the government and
`draw all reasonable inferences and credibility choices in favor of the
`jury’s verdict.” Id. (citation omitted).
`
`As to a restitution order, we rely on three standards of re-
`view. First, we examine the legality of the restitution order de
`novo. United States v. Robertson, 493 F.3d 1322, 1330 (11th Cir.
`2007). After all, “[a] federal district court has no inherent authority
`to order restitution, and may do so only as explicitly empowered
`by statute.” United States v. Valladares, 544 F.3d 1257, 1269 (11th
`Cir. 2008) (quoting United States v. Dickerson, 370 F.3d 1330, 1335
`(11th Cir. 2004)). Second, we review the district court’s determi-
`nation of the restitution value of lost or destroyed property for
`abuse of discretion. Id. And third, we review the factual findings
`underlying the restitution order for clear error. Id.
`
`When assessing a forfeiture order, we review the district
`court’s findings of fact for clear error and its legal conclusions de
`novo. United States v. Goldstein, 989 F.3d 1178, 1202 (11th Cir.
`2021).
`
`III. DISCUSSION
`
`Our discussion proceeds in three parts. We first assess
`whether sufficient evidence supported Young’s conspiracy convic-
`tion. Then, we examine the district court’s restitution order and
`determine whether the court erred in measuring the government’s
`losses from Young’s scheme. Finally, we consider whether the dis-
`trict court erred in ordering Young to forfeit the full amount that
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 17 of 56
`
`20-13091
`
`Opinion of the Court
`
`17
`
`Drugs4Less and Gateway deposited into her account, given that
`she transferred some of that money to co-conspirators.
`A.
`Sufficient evidence supported Young’s convictions.
`
`Young asserts that insufficient evidence supported her con-
`spiracy conviction for two reasons. First, she argues that the gov-
`ernment failed to present enough evidence to support a conspiracy
`involving herself, the Mitchells, and Gateway that ran from August
`2016 to December 2018. Second, as to Drugs4Less and Gateway,
`Young contends that insufficient evidence established that de la
`Cruz or Mitchell served as a decisionmaker who could refer pre-
`scriptions to Drugs4Less or Gateway.
`
`We address her arguments in turn.
`1.
`The jury reasonably concluded that Gateway was involved
`in the conspiracy.
`
`Young argues first that the government failed to prove a
`conspiracy involving the Gateway pharmacy. She acknowledges
`that the government offered several pieces of evidence on this
`count: the Office of Worker’s Compensation Program’s billing
`data; bank records indicating payments from Gateway to Young
`and Mitchell; Mitchell’s testimony that “everything” moved from
`Drugs4Less to Gateway after Young stopped using Drugs4Less;
`and an email from Young to de la Cruz in which Young attached a
`Gateway prescription pad. Still, Young contends that no direct ev-
`idence supports her conviction.
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 18 of 56
`
`18
`
`Opinion of the Court
`
`20-13091
`
`According to Young, the jury could draw only one permissi-
`ble inference from the evidence the government offered: Gateway
`received legitimate payments from the Office of Worker’s Com-
`pensation Programs and then paid Gateway’s legitimate employ-
`ees, Young and Mitchell, money that Young and Mitchell legiti-
`mately earned. Noting that the jury acquitted her on the receipt-
`of-kickbacks counts, Young reasons that the jury couldn’t have
`found that her role in the conspiracy continued once Gateway be-
`came involved because Young was no longer paying Mitchell at
`that time.
`
`We disagree. We’ve observed that “[b]ecause the crime of
`conspiracy is predominantly mental in composition, it is frequently
`necessary to resort to circumstantial evidence to prove its ele-
`ments.” United States v. Watkins, 42 F.4th 1278, 1285 (11th Cir.
`2022) (citation omitted). Indeed, we’ve noted that the government
`may rely entirely on circumstantial evidence to secure a conspiracy
`conviction. See United States v. White, 663 F.3d 1207, 1214 (11th Cir.
`2011) (“Because ‘conspiracies are secretive by nature, the existence
`of an agreement and [defendant’s] participation in the conspiracy
`may be proven entirely from circumstantial evidence.’”) (citation
`omitted). Here, the circumstantial evidence allowed the jury to
`permissibly conclude that Young was involved in a conspiracy with
`Gateway.
`
`First, the government presented Mitchell’s testimony that
`his arrangement with Young largely stayed the same after the core
`conspirators—Young, de la Cruz, and Mitchell—switched the
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 19 of 56
`
`20-13091
`
`Opinion of the Court
`
`19
`
`underlying pharmacy from Drugs4Less to Gateway. In other
`words, Mitchell continued to get paid to do essentially nothing,
`while de la Cruz arranged for the patients to receive prescriptions
`for Terocin and LidoPro and sent them to, now, Gateway. Second,
`the Office of Worker’s Compensation Programs’s financial records
`further support the conclusion that the Terocin and LidoPro pre-
`scription scheme worked in the same way before and after Gate-
`way’s involvement, with merely a change in which pharmacy filled
`the prescription. Third, more than twenty of Dr. James’s patients
`who had received medications from Drugs4Less began receiving
`shipments from Gateway. Fourth, the email from Young to de la
`Cruz included a Gateway prescription, which the jury reasonably
`could have understood to mean that Young and de la Cruz planned
`to continue their scheme in the same way it had operated with
`Drugs4Less. It makes no difference for purposes of the conspiracy
`count that Young no longer paid Mitchell directly because she still
`facilitated the kickback scheme with her co-conspirators.
`
`Based on the evidence, the jury reasonably could have de-
`termined that Young moved the kickback scheme to Gateway be-
`cause Drugs4Less declined to hire Mitchell and her as full-time em-
`ployees, so Young made the switch in an effort to maintain the
`scheme under the guise of legal protection. In short, sufficient ev-
`idence allowed the jury to reasonably conclude that the conspiracy
`continued, even though it ran through a different pharmacy. See
`United States v. Richardson, 532 F.3d 1279, 1286 (11th Cir. 2008) (“A
`conspiracy is presumed to continue until its objectives have been
`abandoned or accomplished.”).
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 20 of 56
`
`20
`
`Opinion of the Court
`
`20-13091
`
`Young points to defense witnesses’ testimony to negate the
`government’s evidence about a continuing conspiracy with Gate-
`way. But at this stage, we must assume that the jury made all cred-
`ibility choices in the verdict’s favor. United States v. Estrada, 969
`F.3d 1245, 1266 (11th Cir. 2020). And the jury could have deter-
`mined that the defense witnesses were not credible. So we decline
`to consider their testimony when evaluating whether the govern-
`ment offered sufficient evidence to convict Young.
`2.
`The jury reasonably concluded that de la Cruz was a deci-
`sionmaker who could refer prescriptions.
`
`The Anti-Kickback Statute makes it unlawful to “knowingly
`and willfully offer[] or pay[] any remuneration (including any kick-
`back, bribe, or rebate) directly or indirectly, overtly or covertly, in
`cash or in kind to any person to induce such person . . . to refer an
`individual to a person for the furnishing or arranging for the fur-
`nishing of any item or service for which payment may be made in
`whole or in part under a Federal health care program[.]” 42 U.S.C.
`§ 1320a-7b(b)(2)(A). Young argues that de la Cruz was not a deci-
`sionmaker with authority to direct the patients’ prescriptions, so
`Young could not have paid de la Cruz “to induce [her] to refer” the
`patients for unlawful purposes.
`
`United States v. Vernon, 723 F.3d 1234 (11th Cir. 2013), fore-
`closes this argument. There, the defendant operated a specialty
`pharmacy, and he paid a “patient advocate” to direct her clients to
`fill their prescriptions at the defendant’s pharmacy. Id. at 1245.
`The patient advocate generally helped her clients by attending
`
`

`

`USCA11 Case: 20-13091 Document: 71-1 Date Filed: 07/22/2024 Page: 21 of 56
`
`20-13091
`
`Opinion of the Court
`
`21
`
`medical appointments with them, helping with routine life tasks,
`and assisting in filling prescriptions. Id. After law enforcem

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket